Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity
- 18 August 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 347 (1) , 208-214
- https://doi.org/10.1016/j.bbrc.2006.06.080
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Novel Approach for Cancer Immunotherapy: Tumor Cells with Anchored Superantigen SEA Generate Effective Antitumor ImmunityJournal of Clinical Immunology, 2004
- Individualized Patient Dosing in Phase I Clinical Trials: The Role of Escalation With Overdose Control in PNU-214936Journal of Clinical Oncology, 2004
- Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γThe Journal of Experimental Medicine, 2002
- Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasisBlood, 2001
- Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinomaHepatology, 1997
- CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xLImmunity, 1995
- Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptorsImmunity, 1994
- Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.The Journal of Experimental Medicine, 1994
- Superantigen‐induced cytokines suppress growth of human colon‐carcinoma cellsInternational Journal of Cancer, 1993
- CD28 and staphylococcal enterotoxins synergize to induce MHC-independent T-cell proliferationCellular Immunology, 1992